Bernadette Connaughton sold $167K of HALO stock

Bernadette Connaughton, Dir of Halozyme Therapeutics, Inc. (HALO), sold 1,626 shares of HALO stock worth $167K, per an SEC Form 4 filed Aug 11, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 10, 2026, 1 day before it was made public.

HALO has moved -0.9% since the trade date, from $102.62 to $101.68 (Nov 11, 2026 close).